Korean J Blood Transfus.
2020 Apr;31(1):67-69. 10.17945/kjbt.2020.31.1.67.
Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019
- Affiliations
-
- 1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
- 2Division of Human Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Cheongju, Korea
- KMID: 2501119
- DOI: http://doi.org/10.17945/kjbt.2020.31.1.67
Abstract
- Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies. Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world. There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus. Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Convalescent Plasma Therapy for Coronavirus Disease 2019
- Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy
- Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
- Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
- A Transient Effect of Convalescent Plasma Therapy in a Patient with Severe Covonavirus Disease 2019: A Case Report
